Literature DB >> 3091435

Metabolic fate of plasma diamine oxidase: evidence of isolated and perfused rat liver uptake.

L D'Agostino, C Ciacci, G Capuano, B Daniele, G D'Argenio, M V Barone, S Rodinò, G Budillon, G Mazzacca.   

Abstract

After injection of an intravenous bolus of heparin (15,000 IU) in two groups of subjects, 10 normal volunteers and 6 subjects with external biliary drainage, blood and urine samples were collected; in the latter group bile samples were collected also. All samples were assayed for diamine oxidase (DAO). Persistently high values of this enzyme were found in plasma of both populations after heparin stimulation, while no increase in enzymatic activity was detected in bile and urine. In order to confirm and support the hepatic clearance of DAO, liver uptake of the enzyme derived from porcine kidney, human plasma and human placenta was studied by perfusion of isolated rat liver. Disappearance curves of the enzyme derived from three different sources showed a prompt liver uptake: activity decreased by about 50% in 10 min (endocytic uptake) and a slower but constant reduction during the remaining 110 min of perfusion was observed. These data suggest the hypothesis of liver metabolism of plasma DAO.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091435     DOI: 10.1159/000199337

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  8 in total

1.  Diamine oxidase as a marker of intestinal mucosal injury and the effect of soluble dietary fiber on gastrointestinal tract toxicity after intravenous 5-fluorouracil treatment in rats.

Authors:  Ian Fukudome; Michiya Kobayashi; Ken Dabanaka; Hiromichi Maeda; Ken Okamoto; Takehiro Okabayashi; Ryoko Baba; Nana Kumagai; Koji Oba; Mamoru Fujita; Kazuhiro Hanazaki
Journal:  Med Mol Morphol       Date:  2013-09-05       Impact factor: 2.309

2.  Factors affecting plasma postheparin diamine oxidase activity.

Authors:  J S Thompson; D A Burnett; W P Vaughan
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

3.  Postheparin plasma diamine oxidase values in the follow up of patients with small bowel Crohn's disease.

Authors:  L D'Agostino; S Pignata; B Daniele; M Visconti; C Ferraro; G D'Adamo; G Tritto; G Ambrogio; G Mazzacca
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

Review 4.  Biomarkers for radiation-induced small bowel epithelial damage: an emerging role for plasma Citrulline.

Authors:  Ludy Lutgens; Philippe Lambin
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

5.  Postheparin plasma diamine oxidase increases in patients with coeliac disease during gluten free diet.

Authors:  L D'Agostino; B Daniele; S Pignata; M V Barone; C Ciacci; R Sollazzo; G Mazzacca
Journal:  Gut       Date:  1987       Impact factor: 23.059

6.  Oligomannosidic glycans at Asn-110 are essential for secretion of human diamine oxidase.

Authors:  Elisabeth Gludovacz; Daniel Maresch; Leonor Lopes de Carvalho; Verena Puxbaum; Laurenz J Baier; Leander Sützl; Gabriela Guédez; Clemens Grünwald-Gruber; Barbara Ulm; Sophie Pils; Robin Ristl; Friedrich Altmann; Bernd Jilma; Tiina A Salminen; Nicole Borth; Thomas Boehm
Journal:  J Biol Chem       Date:  2017-11-29       Impact factor: 5.486

7.  Human diamine oxidase is readily released from activated neutrophils ex vivo and in vivo but is rarely elevated in bacteremic patients.

Authors:  Thomas Boehm; Matthias Karer; Peter Matzneller; Nina Buchtele; Franz Ratzinger; Karin Petroczi; Christian Schoergenhofer; Michael Schwameis; Heinz Burgmann; Markus Zeitlinger; Bernd Jilma
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

8.  Heparin-binding motif mutations of human diamine oxidase allow the development of a first-in-class histamine-degrading biopharmaceutical.

Authors:  Elisabeth Gludovacz; Kornelia Schuetzenberger; Marlene Resch; Katharina Tillmann; Karin Petroczi; Markus Schosserer; Sigrid Vondra; Serhii Vakal; Gerald Klanert; Jürgen Pollheimer; Tiina A Salminen; Bernd Jilma; Nicole Borth; Thomas Boehm
Journal:  Elife       Date:  2021-09-03       Impact factor: 8.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.